Mylan Pharmaceuticals is recalling 38,412 bottles of Amlodipine and Benazapril HCL Capsules, a medication used to treat high blood pressure. Approximately 25,488 bottles of the 5 mg/10 mg strength and 12,924 bottles of the 5 mg/40 mg strength are affected. The recall was initiated because the cleaning procedures for the equipment used to manufacture these specific batches were not properly followed, which could lead to cross-contamination between different drug products.
Failure to follow proper equipment cleaning procedures creates a risk that residue from previously manufactured drugs could contaminate these capsules. This cross-contamination may cause patients to be exposed to unintended medications, potentially leading to adverse reactions or reduced effectiveness of their blood pressure treatment.
Contact healthcare provider and return to pharmacy.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.